This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Cataflam

Novartis AG

Drug Names(s): Diclofenac sodium

Description: Cataflam is the potassium salt of diclofenac. It is thought its anti-inflammatory and analgesic actions are due to inhibition of prostaglandin synthesis by inhibition of cyclooxygenase (COX). Inhibition of COX decreases prostaglandins in the epithelium of the stomach. Cataflam has a low to moderate preference to block the COX2-isoenzyme (approximately 10-fold) and has a lower incidence of gastrointestinal complaints compared to similar drugs.


Cataflam News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug